Topic resource collection
Approved comparison material connected to this topic.
479 resourcesRead both sides
Sleep peptides fall into three categories based on mechanism: GABA potentiators (which increase inhibitory neurotransmission to induce drowsiness), circadian modulators (which restore disrupted melatonin rhythms), and adenosine r…
BPC-157 VEGF upregulation, FAK-paxillin pathway activation → axonal outgrowth Rat sciatic nerve transection model: 40% faster motor recovery vs saline (2020, Eur J Pharmacol) 250–500mcg SubQ daily No Phase 2+ human trials in neur…
| Peptide | Primary Mechanism | Thyroid Function Impact | Metabolic Rate Effect | Insulin Sensitivity | Evidence Quality | Professional Assessment ||—|—|—|—|—|—|| Thymalin | TSH pulse modulation, thyroid follicle protection | Dir…
| Peptide | Primary Mechanism | Recovery Target | Typical Research Dose | Time to Effect | Professional Assessment ||—|—|—|—|—|| Thymalin | Thymic epithelial cell stimulation, T-cell maturation | Immune suppression, illness frequ…
Before choosing any research compound, understand what 'works' means in this context. Peptides for anxiety aren't FDA-approved medications with standardized dosing and safety profiles. The table below ranks them by strength of hu…
This table compares the five peptides by their primary mechanism, required administration route, evidence base, and typical research dosing. The bottom line column synthesises when each peptide is the optimal choice based on the …
Beta-defensins (hBD-1, hBD-2, hBD-3) Yes. MIC 2–8 μg/mL against C. albicans Membrane disruption via pore formation Multiple in vitro studies; limited human trials Strongest documented anti-Candida activity but not orally bioavail…
BPC-157 VEGF upregulation, angiogenesis, FAK-paxillin pathway activation Case reports and observational data only. No RCTs in diabetic neuropathy Subcutaneous or intramuscular injection 250–500 mcg daily in research models Strong…
GHK-Cu (Copper Peptide) Activates lysyl oxidase to cross-link collagen; downregulates IL-6 and TNF-α inflammatory cytokines Topical (penetrates at 340 Daltons) or microneedling Atrophic scars, mature scars needing remodeling High…
| Peptide | Primary Mechanism | Injury Type Efficacy | Typical Dose Range | Administration Route | Evidence Grade (A–D) | Professional Assessment ||—|—|—|—|—|—|| BPC-157 | VEGF upregulation, angiogenesis | Tendon, ligament, muscl…
GHK-Cu (Copper Peptide) TGF-β1 suppression, lysyl oxidase activation, organized collagen synthesis Microneedling + topical serum (2–5% concentration), or iontophoresis 2–5% topical serum applied 2× daily, or 0.1–0.5 mA iontophore…
The gap between animal models and human clinical trials is where most peptide therapies stall. BPC-157 has robust preclinical data across nerve crush injuries, diabetic neuropathy models, and chemotherapy-induced peripheral neuro…
The three dominant mechanisms among true nootropic peptides are CREB pathway activation, BDNF receptor agonism, and HGF/c-Met potentiation. Each produces measurable cognitive enhancement, but the timelines, durability, and specif…
PT-141 (Bremelanotide) MC4R agonist. Direct hypothalamic arousal signaling 30–90 minutes subcutaneous Phase 3 RCT data (RECONNECT). FDA-approved for HSDD Nausea (40–60%), flushing (25–35%), transient hypotension (10%) Strongest c…
The following table compares the best peptides for chronic inflammation by mechanism, evidence base, and typical research dosing protocols used in published studies. BPC-157 VEGFR2 agonism, angiogenesis promotion, NF-κB modulatio…
Different peptides address distinct underlying mechanisms. Choosing the right compound depends on whether the libido deficit stems from central arousal pathways, hormonal axis suppression, or emotional/pair-bonding impairment. Th…
Selecting the appropriate peptide for cognitive decline research requires matching mechanism to research question. The table below compares primary mechanisms, administration routes, and key research applications for leading cogn…
The following comparison table evaluates the primary research peptides investigated for tendon and connective tissue repair based on mechanism of action, documented preclinical effects, typical research protocols, and key conside…
The following table compares the primary peptides studied for metabolic syndrome intervention based on mechanism, clinical evidence, and metabolic targets. This comparison is drawn from peer-reviewed trials and preclinical studie…
The table below summarizes the peptides demonstrating the strongest evidence base for cardiac protection, their primary mechanisms, and the clinical or preclinical endpoints they've shown to improve. SS-31 (Elamipretide) Mitochon…